{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:58:41Z","timestamp":1769054321867,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11596-020-2250-9","type":"journal-article","created":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T04:11:46Z","timestamp":1601179906000},"page":"885-899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma"],"prefix":"10.1007","volume":"40","author":[{"given":"Hai-xia","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"issue":"2","key":"2250_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2009.01.002","volume":"72","author":"LD Leval","year":"2009","unstructured":"Leval LD, Bisig B, Thielen C, et al. Molecular classification of T-cell lymphomas. Crit Rev Oncol Hematol, 2009,72(2):125\u2013143","journal-title":"Crit Rev Oncol Hematol"},{"issue":"25","key":"2250_CR2","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","volume":"117","author":"FM Foss","year":"2011","unstructured":"Foss FM, Zinzani PL, Vose JM, et al. Peripheral T-cell lymphoma. Blood, 2011,117(25):6756\u20136767","journal-title":"Blood"},{"key":"2250_CR3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.23144","volume":"87","author":"J O Armitage","year":"2012","unstructured":"Armitage James O.. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management. Am. J. Hematol, 2012,87:511\u2013519","journal-title":"Am. J. Hematol"},{"issue":"6","key":"2250_CR4","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","volume":"170","author":"JJ Scarisbrick","year":"2014","unstructured":"Scarisbrick JJ, Kim YH, Whittaker SJ, et al. Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now? Br J Dermatol, 2014,170(6):1226\u20131236","journal-title":"Br J Dermatol"},{"issue":"9","key":"2250_CR5","doi-asserted-by":"crossref","first-page":"e112148","DOI":"10.1371\/journal.pone.0112148","volume":"9","author":"E Martin-Sanchez","year":"2014","unstructured":"Martin-Sanchez E, Odqvist L, Rodriguez-Pinilla SM, et al. PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases. Plos One, 2014,9(9):e112148","journal-title":"Plos One"},{"issue":"4","key":"2250_CR6","first-page":"123253","volume":"2012","author":"J D Pearson","year":"2012","unstructured":"Pearson Joel D, Lee Jason KH, Bacani Julinor TC, et al. NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases. J Signal Transduct, 2012,2012(4):123253","journal-title":"J Signal Transduct"},{"issue":"1","key":"2250_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/JME-11-0004","volume":"47","author":"A Barreca","year":"2011","unstructured":"Barreca A, Lasorsa E, Riera L, et al. Anaplastic lymphoma kinase in human cancer. J Mol Endocrinol, 2011,47(1):11\u201323","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"2250_CR8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MOH.0b013e32832b89a9","volume":"16","author":"H O\u2019Leary","year":"2009","unstructured":"O\u2019Leary H, Savage KJ. The spectrum of peripheral T-cell lymphomas. Curr Opin Hematol, 2009,16(4):292","journal-title":"Curr Opin Hematol"},{"issue":"8","key":"2250_CR9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMc1013224","volume":"364","author":"C Gambacorti-Passerini","year":"2011","unstructured":"Gambacorti-Passerini C, Messa C, Pogliani EM. Crizotinib in anaplastic large-cell lymphoma. N Engl J Med, 2011,364(8):775\u2013776","journal-title":"N Engl J Med"},{"issue":"3","key":"2250_CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12185-014-1521-2","volume":"99","author":"AM Intlekofer","year":"2014","unstructured":"Intlekofer AM, Younes A. From empiric to mechanism-based therapy for peripheral T cell lymphoma. Int J Hematol, 2014,99(3):249\u2013262","journal-title":"Int J Hematol"},{"issue":"20","key":"2250_CR11","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1182\/blood-2013-12-542142","volume":"123","author":"SM Horwitz","year":"2014","unstructured":"Horwitz SM, Advani RH, Bartlett NL, et al. Objective responses in relapsed T-cell lymphomas with singleagent brentuximab vedotin. Blood, 2014,123(20):3095\u20133100","journal-title":"Blood"},{"issue":"23","key":"2250_CR12","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1158\/1078-0432.CCR-09-1995","volume":"16","author":"K Dunleavy","year":"2010","unstructured":"Dunleavy K, Piekarz RL, Zain J, et al. New Strategies in Peripheral T-cell lymphoma: Understanding Tumor Biology and Developing Novel Therapies. Clin Cancer Res, 2010,16(23):5608","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2250_CR13","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1182\/blood-2013-12-516245","volume":"123","author":"AJ Moskowitz","year":"2014","unstructured":"Moskowitz AJ, Lunning MA, Horwitz SM. How I treat the peripheral T-cell lymphomas. Blood, 2014,123(17):2636\u20132644","journal-title":"Blood"},{"issue":"3","key":"2250_CR14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","volume":"117","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest, 2007,117(3):823\u2013834","journal-title":"J Clin Invest"},{"issue":"14","key":"2250_CR15","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics, 2007,23(14):1846\u20131847","journal-title":"Bioinformatics"},{"issue":"1","key":"2250_CR16","first-page":"25","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet, 2000,25(1):25\u201329","journal-title":"The Gene Ontology Consortium. Nat Genet"},{"issue":"1","key":"2250_CR17","first-page":"29","volume":"27","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 2000,27(1):29\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2250_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 2009,4(1):44\u201357","journal-title":"Nat Protoc"},{"key":"2250_CR19","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, et al.. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res, 2015,43:D447","journal-title":"Nucleic Acids Res"},{"key":"2250_CR20","doi-asserted-by":"crossref","unstructured":"Ono K, Muetze T, Kolishovski G, et al. CyREST: Turbocharging Cytoscape Access for External Tools via a RESTful API. F1000Res, 2015,4","DOI":"10.12688\/f1000research.6767.1"},{"issue":"1","key":"2250_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics, 2003,4(1):2","journal-title":"BMC Bioinformatics"},{"issue":"20","key":"2250_CR22","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, 2016,127(20):2375\u20132390","journal-title":"Blood"},{"issue":"15","key":"2250_CR23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","volume":"126","author":"C Wang","year":"2015","unstructured":"Wang C, Mckeithan TW, Gong Q, et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood, 2015,126(15):1741\u20131752","journal-title":"Blood"},{"issue":"3","key":"2250_CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12185-014-1522-1","volume":"99","author":"PP Piccaluga","year":"2014","unstructured":"Piccaluga PP, Tabanelli V, Pileri SA. Molecular genetics of peripheral T-cell lymphomas. Int J Hematol, 2014,99(3):219\u2013226","journal-title":"Int J Hematol"},{"issue":"1","key":"2250_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-cellbio-111315-125341","volume":"32","author":"EK Paluch","year":"2016","unstructured":"Paluch EK, Aspalter IM, Sixt M. Focal Adhesion-Independent Cell Migration. Annu Rev Cell Dev Biol, 2016,32(1):469","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"9","key":"2250_CR26","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1017\/S1751731114001323","volume":"8","author":"JJ Zhu","year":"2014","unstructured":"Zhu JJ, Luo J, Wang W, et al. Inhibition of FASN reduces the synthesis of medium-chain fatty acids in goat mammary gland. Animal, 2014,8(9):1469\u20131478","journal-title":"Animal"},{"issue":"42","key":"2250_CR27","doi-asserted-by":"crossref","first-page":"72182","DOI":"10.18632\/oncotarget.20053","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang M, Xu H, et al. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK\/ERK signaling pathway. Oncotarget, 2017,8(42):72182\u201372196","journal-title":"Oncotarget"},{"issue":"2","key":"2250_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1101\/gad.1856710","volume":"24","author":"JM Morachis","year":"2010","unstructured":"Morachis JM, Murawsky CM, Emerson BM. Regulation of the p53 transcriptional response by structurally diverse core promoters. Genes Dev, 2010,24(2):135\u2013147","journal-title":"Genes Dev"},{"issue":"10","key":"2250_CR29","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1158\/1535-7163.MCT-17-0089","volume":"16","author":"S Islam","year":"2017","unstructured":"Islam S, Qi W, Morales C, et al. Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas. Mol Cancer Ther, 2017,16(10):2083\u20132093","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"2250_CR30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","volume":"128","author":"JR La","year":"2016","unstructured":"Jr LA, Schafernak KT, Geyer JT, et al. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. Blood, 2016,128(8):1093\u20131100","journal-title":"Blood"},{"issue":"10","key":"2250_CR31","first-page":"1","volume":"37","author":"Y Li","year":"2016","unstructured":"Li Y, Shi X, Yang W, et al. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing. Tumour Biol, 2016,37(10):1\u201310","journal-title":"Tumour Biol"},{"issue":"4","key":"2250_CR32","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.3892\/ol.2017.6707","volume":"14","author":"S Li","year":"2017","unstructured":"Li S, Li H, Xu Y, et al. Identification of candidate biomarkers for epithelial ovarian cancer metastasis using microarray data. Oncol Lett, 2017,14(4):3967\u20133974","journal-title":"Oncol Lett"},{"key":"2250_CR33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2147\/OTT.S131386","volume":"10","author":"X Ning","year":"2017","unstructured":"Ning X, Deng Y.. Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma. Onco Targets Ther, 2017,10:1673\u20131686","journal-title":"Onco Targets Ther"},{"issue":"16","key":"2250_CR34","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1021\/acs.jmedchem.6b00487","volume":"59","author":"GR Ott","year":"2016","unstructured":"Ott GR, Cheng M, Learn KS, et al. Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK). J Med Chem, 2016,59(16):7478\u20137496","journal-title":"J Med Chem"},{"issue":"1","key":"2250_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/his.12381","volume":"65","author":"R Bosch","year":"2014","unstructured":"Bosch R, Dieguez-Gonzalez R, Moreno MJ, et al. Focal adhesion protein expression in human diffuse large B-cell lymphoma. Histopathology, 2014,65(1):119\u2013131","journal-title":"Histopathology"},{"issue":"13","key":"2250_CR36","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","volume":"108","author":"S Uddin","year":"2006","unstructured":"Uddin S, Hussain AR, Siraj AK, et al. Role of phosphatidylinositol 3,-kinase\/AKT pathway in diffuse large B-cell lymphoma survival. Blood, 2006,108(13):4178\u20134186","journal-title":"Blood"},{"issue":"4","key":"2250_CR37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2141.2010.08123.x","volume":"149","author":"S Hasselblom","year":"2010","unstructured":"Hasselblom S, Hansson U, Olsson M, et al. High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Br J Haematol, 2010,149(4):560\u2013568","journal-title":"Br J Haematol"},{"issue":"1","key":"2250_CR38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/annonc\/mdt530","volume":"25","author":"JY Hong","year":"2014","unstructured":"Hong JY, Hong ME, Choi MK, et al. The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases. Ann Oncol, 2014,25(1):182\u2013188","journal-title":"Ann Oncol"},{"issue":"13","key":"2250_CR39","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood.V96.13.4319","volume":"96","author":"R Bai","year":"2000","unstructured":"Bai R, Ouyang TC, Morris S, et al. Nucleophosminanaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase\/Akt antiapoptotic signaling pathway. Blood, 2000,96(13):4319","journal-title":"Blood"},{"issue":"2","key":"2250_CR40","first-page":"274","volume":"90","author":"C Chow","year":"2005","unstructured":"Chow C, Liu AY, Chan WS, et al. AKT plays a role in the survival of the tumor cells of extranodal NK\/T-cell lymphoma, nasal type. Haematologica, 2005,90(2):274","journal-title":"Haematologica"},{"issue":"6","key":"2250_CR41","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2010","unstructured":"Huang Y, De RA, De LL, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type. Blood, 2010,115(6):1226","journal-title":"Blood"},{"issue":"2","key":"2250_CR42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2004-06-2125","volume":"105","author":"GZ Rassidakis","year":"2005","unstructured":"Rassidakis GZ, Feretzaki M, Atwell C, et al. Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma. Blood, 2005,105(2):827\u2013829","journal-title":"Blood"},{"issue":"5","key":"2250_CR43","first-page":"2194","volume":"61","author":"A Slupianek","year":"2001","unstructured":"Slupianek A, Nieborowska-Skorska M, Hoser G, et al. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin\/anaplastic lymphoma kinase-mediated lymphomagenesis. Cancer Res, 2001,61(5):2194\u20132199","journal-title":"Cancer Res"},{"issue":"15","key":"2250_CR44","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood-2009-06-222794","volume":"114","author":"Y Yamanaka","year":"2009","unstructured":"Yamanaka Y, Tagawa H, Takahashi N, et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma\/leukemia. Blood, 2009,114(15):3265\u20133275","journal-title":"Blood"},{"issue":"4","key":"2250_CR45","first-page":"2465","volume":"35","author":"JY Hong","year":"2015","unstructured":"Hong JY, Hong ME, Choi MK, et al. The Clinical Significance of Activated p-AKT Expression in Peripheral T-cell Lymphoma. Anticancer Res, 2015,35(4):2465\u20132474","journal-title":"Anticancer Res"},{"issue":"3","key":"2250_CR46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1189\/jlb.1RI0614-293R","volume":"97","author":"W Huang","year":"2015","unstructured":"Huang W, August A. The signaling symphony: T cell receptor tunes cytokine-mediated T cell differentiation. J Leukoc Biol, 2015,97(3):477\u2013485","journal-title":"J Leukoc Biol"},{"issue":"12","key":"2250_CR47","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","volume":"19","author":"DB Martinez","year":"2005","unstructured":"Martinez DB, Cuadros ME, Ruizdl PA, et al. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia, 2005,19(12):2254","journal-title":"Leukemia"},{"issue":"4","key":"2250_CR48","doi-asserted-by":"crossref","first-page":"e35378","DOI":"10.1371\/journal.pone.0035378","volume":"7","author":"L Xiang","year":"2012","unstructured":"Xiang L, Xie G, Ou J, et al. The Extra Domain A of Fibronectin Increases VEGF-C Expression in Colorectal Carcinoma Involving the PI3K\/AKT Signaling Pathway. Plos One, 2012,7(4):e35378","journal-title":"Plos One"},{"key":"2250_CR49","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","volume":"350","author":"IS Lossos","year":"2004","unstructured":"Lossos IS, Czerwinski DK, Alizadeh AA, et al.. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med, 2004,350:1828\u20131837","journal-title":"N Engl J Med"},{"issue":"12","key":"2250_CR50","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1182\/blood-2008-02-136374","volume":"111","author":"R Malumbres","year":"2008","unstructured":"Malumbres R, Chen J, Tibshirani R, et al. Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Blood, 2008,111(12):5509","journal-title":"Blood"},{"issue":"12","key":"2250_CR51","doi-asserted-by":"crossref","first-page":"e8173","DOI":"10.1371\/journal.pone.0008173","volume":"4","author":"G Vanesa","year":"2009","unstructured":"Vanesa G, Miguel GJ, Javier S, et al. Extracellular Tumor-Related mRNA in Plasma of Lymphoma Patients and Survival Implications. Plos One, 2009, 4(12):e8173","journal-title":"Plos One"},{"issue":"1","key":"2250_CR52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12917-016-0919-x","volume":"13","author":"M Zamani-Ahmadmahmudi","year":"2017","unstructured":"Zamani-Ahmadmahmudi M, Aghasharif S, Ilbeigi K. Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart. BMC Vet Res, 2017,13(1):17","journal-title":"BMC Vet Res"},{"issue":"6","key":"2250_CR53","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG. Biomarkers for epithelialmesenchymal transitions. J Clin Invest, 2009,119(6):1429\u20131437","journal-title":"J Clin Invest"},{"issue":"1","key":"2250_CR54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2162-3619-2-27","volume":"2","author":"S Brandt","year":"2013","unstructured":"Brandt S, Montagna C, Georgis A, et al. The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Exp Hematol Oncol, 2013,2(1):27","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2250_CR55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13046-015-0132-y","volume":"34","author":"H Zhang","year":"2015","unstructured":"Zhang H, Teng X, Liu Z, et al. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis. J Exp Clin Cancer Res, 2015,34(1):16","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"2250_CR56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.biocel.2005.11.011","volume":"38","author":"R Zenz","year":"2006","unstructured":"Zenz R, Wagner EF. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors. Int J Biochem Cell Biol, 2006,38(7):1043\u20131049","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"2250_CR57","doi-asserted-by":"crossref","first-page":"16019","DOI":"10.1038\/s41598-018-34199-9","volume":"8","author":"J Zhang","year":"2018","unstructured":"Zhang J, Wu Z, Savin A, et al. The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G1. Sci Rep, 2018,8(1):16019","journal-title":"Sci Rep"},{"issue":"5","key":"2250_CR58","first-page":"1163","volume":"137","author":"LP Ruco","year":"1990","unstructured":"Ruco LP, Pomponi D, Pigott R, et al. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin\u2019s disease, and in non-Hodgkin\u2019s lymphomas. An immunocytochemical study. Am J Pathol, 1990,137(5):1163\u20131171","journal-title":"An immunocytochemical study. Am J Pathol"},{"issue":"4","key":"2250_CR59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3960\/jslrt.54.117","volume":"91","author":"N Goto","year":"2014","unstructured":"Goto N, Tsurumi H, Takemura M, et al. Serum Soluble Tumor Necrosis Factor Receptor 1 Level is Associated with the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with the CHOP or R-CHOP Regimen. J Clin Exp Hematop, 2014,91(4):117\u2013127","journal-title":"J Clin Exp Hematop"},{"issue":"4","key":"2250_CR60","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/ejh.12139","volume":"91","author":"N Nakamura","year":"2013","unstructured":"Nakamura N, Goto N, Tsurumi H, et al. Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen. Eur J Haematol, 2013,91(4):322\u2013331","journal-title":"Eur J Haematol"},{"issue":"2","key":"2250_CR61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/PAS.0000000000000094","volume":"38","author":"Y Honma","year":"2014","unstructured":"Honma Y, Sugita N, Kobayashi T, et al. TNF-\u03b1 expression in tumor cells as a novel prognostic marker for diffuse large B-cell lymphoma, not otherwise specified. Am J Surg Pathol, 2014,38(2):228\u2013234","journal-title":"Am J Surg Pathol"},{"key":"2250_CR62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.leukres.2017.05.014","volume":"59","author":"I Dlouhy","year":"2017","unstructured":"Dlouhy I, Filella X, Rovira J, et al.. High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma. Leuk Res, 2017,59:20","journal-title":"Leuk Res"},{"issue":"1\u20132","key":"2250_CR63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10428199409114149","volume":"16","author":"H Kato","year":"1994","unstructured":"Kato H, Nagasaka T, Ichikawa A, et al. Tumor necrosis factor-beta gene expression and its relationship to the clinical features and histopathogenesis of peripheral T-cell lymphomas. Leuk Lymphoma, 1994,16(1\u20132):125\u2013133","journal-title":"Leuk Lymphoma"},{"key":"2250_CR64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaut.2017.02.001","volume":"80","author":"G Nocturne","year":"2017","unstructured":"Nocturne G, Boudaoud S, Ly B, et al.. Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas. J Autoimmun, 2017,80:56\u201364","journal-title":"J Autoimmun"},{"issue":"4","key":"2250_CR65","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00430-017-0506-1","volume":"206","author":"S Ramezani","year":"2017","unstructured":"Ramezani S, Shirdel A, Rafatpanah H, et al. Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia\/lymphoma. Med Microbiol Immunol, 2017,206(4):327\u2013335","journal-title":"Med Microbiol Immunol"},{"issue":"48","key":"2250_CR66","doi-asserted-by":"crossref","first-page":"79637","DOI":"10.18632\/oncotarget.12876","volume":"7","author":"M Boi","year":"2016","unstructured":"Boi M, Todaro M, Vurchio V, et al. Therapeutic efficacy of the bromodomain inhibitor OTX015\/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes. Oncotarget, 2016,7(48):79637\u201379653","journal-title":"Oncotarget"},{"issue":"29","key":"2250_CR67","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1038\/onc.2017.90","volume":"36","author":"X Guo","year":"2017","unstructured":"Guo X, Koff JL, Moffitt AB, et al. Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. Oncogene, 2017,36(29):4224\u20134232","journal-title":"Oncogene"},{"issue":"15","key":"2250_CR68","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.yexcr.2007.05.028","volume":"313","author":"A Sebesty\u00e9n","year":"2007","unstructured":"Sebesty\u00e9n A, Hajdu M, Kis L, et al. Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells. Exp Cell Res, 2007,313(15):3167\u20133174","journal-title":"Exp Cell Res"},{"issue":"3","key":"2250_CR69","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V87.3.1147.bloodjournal8731147","volume":"87","author":"I Macdonald","year":"1996","unstructured":"Macdonald I, Wang H, Grand R, et al. Transforming growth factor-beta 1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines. Blood, 1996,87(3):1147","journal-title":"Blood"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-020-2250-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T11:37:48Z","timestamp":1696765068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-020-2250-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2250"],"URL":"https:\/\/doi.org\/10.1007\/s11596-020-2250-9","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"22 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}